Add time:09/06/2019         Source:sciencedirect.com

BackgroundThe aims of this work were to enhance the solubility of nifedipine in acidic medium; to formulate and characterize tab-in-tab dosage form for immediate release of nifedipine and controlled release of ramipril and to avoid the mutual interactions of drugs. This combination appreciably intended to reduce the incidence of peripheral edema and reflex tachycardia.

We also recommend Trading Suppliers and Manufacturers of nifedipine iMpurity C (cas 111304-31-5). Pls Click Website Link as below: cas 111304-31-5 suppliers